Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Ascendis Pharma

Youtube Subscribe

...

Ticker: ASND

Sector: Biotechnology

Ascendis Pharma A/S focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD) The company also develops TransCon Growth Hormone for treating pediatric.
...
...
Extended Summary

Ascendis Pharma

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/? for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Related Results

...
March 02, 2024 12:42 (London Time)

Ascendis Pharma

UBS Group AGs holdings in Ascendis Pharma A/S were worth $4,048,000 as of its most recent filing with the SEC. UBS has a 12-month low of $64.33 and …
Sector: Biotechnology
Ticker: ASND
Sentiment: 0.6486
MarketCap: 8,631,995,280.0
High: 154.75 Low: 147.58

Open: 148.05 Close: 152.47 Change: 4.42

Read more →
...
April 28, 2023 2:48 (London Time)

Ascendis Pharma

Pomerantz LLP is investigating claims on behalf of investors of Ascendis Pharma A/S (ASND) Focused on bringing TransCon™ PTH to U.S. Focused. on bri…
Sector: Biotechnology
Ticker: ASND
Sentiment: 0.7342
MarketCap: 4,399,584,256
High: 77.56 Low: 74.87

Open: 76.44 Close: 76.98 Change: 0.54

Read more →
...
September 18, 2023 14:05 (London Time)

Ascendis Pharma

European Medicines Agencys (EMA) advisory panel, CHMP, recommends approval of drug candidate TransCon PTH (palopegteriparatide) Hedge funds have rec…
Sector: Biotechnology
Ticker: ASND
Sentiment: 0.9652
MarketCap: 5,771,785,835.0
High: 102.81 Low: 101.06

Open: 102.66 Close: 101.11 Change: -1.56

Read more →
Search
Happening Now
Categories